1.
One of the most important tools for diagnosis, analysis, and study of cancer tissues is immunolabeling. Simultaneously analyzing both expression and spatial data of key s [...]
2022 | Abstract |
2.
Adoptive T cell immunotherapy has shown significant promise in advanced melanoma, with over half of patients who failed standard treatments achieving objective clinical r [...]
2009 | Dissertation |
3.
Mechanisms of immune suppression in peripheral tissues counteract protective immu-nity to prevent immunopathology and are coopted by tumors for immune evasion. Blood and [...]
2019 | Dissertation |
4.
5.
Oregon has one of the highest incidence rates of melanoma in the country. Despite the preventable nature of melanoma, there is no formal statewide, high school-based educ [...]
2020 | Abstract |
6.
Tissue-resident memory T cells (TRM) are enriched in nonlymphoid barrier organs where they typically reside long-term without recirculating. These cells are functionally [...]
2024 | Abstract |
7.
Shared decision-making integrates patient values with clinical evidence and is paramount in patient-doctor collaboration. Dermatology is especially appropriate for such c [...]
2024 | Abstract |
8.
Cancer treatment has advanced rapidly in the past decade, with checkpoint inhibitors (CPIs) delivering improved outcomes across a variety of malignant indications. Howeve [...]
2024 | Abstract |
9.
The incidence of malignant melanoma has risen substantially in the United States over recent decades, with solar ultraviolet (UV) radiation recognized as a key causal fac [...]
2008 | Thesis |
10.
This dissertation showcases three independent studies that address various unknown aspects of a paraneoplastic syndrome called melanoma-associated retinopathy (MAR). Thro [...]
2024-11-12 | Dissertation |